Previous functional studies aimed at investigating CD44+/CD24− cells primarily used fluorescence-activated cell sorting (FACS), which assesses cell surface protein expression [2],[10]; we therefore considered the immunostaining to be positive exclusively when it was localised along the cell membrane of cancer cells. The gene discussed is CD44; the disease is cancer.